Abstract
The BioLogue International Symposium on Adaptive Clinical Trials was held October 10, 2006, in Copenhagen, Denmark. This symposium brought together clinical trialists and trial experts from academia, industry, and regulatory agencies to initiate a dialogue on opportunities, scope, and challenges regarding adaptive clinical trials.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Gallo P, Chuang-Stein C, Dragalin V, et al. Adaptive designs in clinical drug development—an executive summary of the PhRMA Working Croup. J Biopharm Stat. 2006;16:275–283.
Dragalin V. Adaptive designs: terminology and classification. Drug Inf J. 2006;40(4):421–484.
For more information, see www.fda.gov/oc/initiatives/criticalpath/and www.fda.gov/oc/speeches/trialdesign0710.html.
The Innovative Medicines Initiative (IMI): Strategic Research Agenda Creating Biomedical R&D Leadership for Europe to Benefit Patients and Society. Available at http://www.efpia.org/4_pos/SRA.pdf. Accessed October 10, 2006.
Committee for Medicinal Products for Human Use (CHMP). Draft reflection paper on methodological issues in confirmatory clinical trials with flexible design and analvsis plan. London. March 23, 2006; Doc. Ref. CHMP/EWP/2459/02. Available at: http://www.emea.europa.eu/pdfs/human/ewp/245902en.pdf. Accessed October 10, 2006.
Gluud C. The culture of designing hepato-biliary trials. J Hepatol. 2006;44:607–615.
Gluud LL. Bias in clinical intervention research. Am J Epidemiol. 2006;163:493–501.
Higgins JPT, Green S. eds. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]. Available at: http://www.cochrane.org/resources/handbook/hbook.htm. Accessed March 26, 2006.
World Health Organization. Research for health: a position paper on WHO’s role and responsibilities in health research. ACHR45/05.16 Rev.1: 2006:1–28. Available at http://www.who.int/rpc/meetings/position_paper.pdf. Accessed November 7, 2006.
Young C, Horton R. Putting clinical trials into context. Lancet. 2005;366:107–108.
Wetterslev J. Thorlund K. Brok J. Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol. In press.
Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analyses of six Cochrane Neonatal Review Croup meta-analyses using actual information size. Clin Trials. 2005;2(suppl 1):32–33.
Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analyses of six Cochrane Neonatal Review Croup meta-analyses considering adequacy of allocation concealment. Clin Trials. 2005;2(suppt 1):61–62.
Thorlund K, Wetterslev J. Brok J. Gluud C. Trial sequential analyses of six Cochrane Neonatal Review Group meta-analyses considering heterogeneity and trial weight. Clin Trials. 2005;2(suppl 1):62.
Thorlund K, Wetterslev J, Brok J, Gluud C. Heterogeneity sample size correction factor for meta-analyses. Poster 141 Abstract. XIII. Cochrane Colloq. 2005:146.
Brok J, Thorlund K, Wetterslev J, Gluud C. Trial sequential analyses of positive Cochrane neonatal meta-analyses considering adequacy of allocation concealment. Clin Trials. 2006;3: 241.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gluud, C., Dejgaard, A., Krams, M. et al. International Symposium on Adaptive Clinical Trial Designs. Ther Innov Regul Sci 42, 93–97 (2008). https://doi.org/10.1177/009286150804200113
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1177/009286150804200113